Filter
2186
Filtered Results: 2186
Text search:
medicines
financing
Featured
Recommendations
159
New Publications
706
Language
Document type
No document type
1283
Studies & Reports
449
Guidelines
164
Strategic & Response Plan
139
Manuals
93
Fact sheets
21
Situation Updates
15
Training Material
12
Infographics
5
Resource Platforms
4
Brochures
1
Countries / Regions
Global
110
Kenya
95
Sierra Leone
56
Uganda
56
Ethiopia
55
Liberia
51
Western and Central Europe
50
India
49
Nigeria
47
Africa
43
Malawi
42
Zambia
41
Myanmar / Burma
41
Ghana
40
Nepal
39
Ukraine
39
Bangladesh
36
Rwanda
35
South Africa
34
Latin America and the Carribbean
31
Tanzania
31
Eastern Europe
29
Asia
21
Namibia
21
South–East Asia Region
17
Zimbabwe
16
Philippines
16
East and Southern Africa
16
Mozambique
15
Cambodia
15
Lesotho
14
Syria
13
Senegal
13
Congo, Democratic Republic of
13
Botswana
13
Guinea
12
Haiti
12
West and Central Africa
12
Indonesia
12
Middle East and North Africa
10
Cameroon
9
Venezuela
8
Eastern Europe and Central Asia
8
Russia
8
Eswatini/ Swaziland
8
Pakistan
8
Benin
7
Burkina Faso
7
Afghanistan
6
Paraguay
6
Moldova
6
Sudan
6
Tajikistan
5
Western Pacific Region
5
Yemen
5
Georgia
5
South Sudan
5
Somalia
5
North Macedonia
4
Thailand
4
Laos
4
Jordan
4
Germany
4
Vietnam
4
Gambia
3
Albania
3
Peru
3
North America
3
Lebanon
3
Brazil
3
Ecuador
3
Turkey
2
Kazakhstan
2
Chile
2
Iran
2
Kyrgyzstan
2
Qatar
2
Jamaica
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Egypt
2
Palestine
2
Central African Republic
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
China
1
Niger
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Armenia
1
USA
1
Lithuania
1
Saudi Arabia
1
Turkmenistan
1
Japan
1
Belgium
1
Mauritius
1
Bosnia and Herzegovina
1
Papua New Guinea
1
Djibouti
1
Mali
1
Chad
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
960
Public Health
156
Clinical Guidelines
109
Women & Child Health
87
Key Resources
73
Pharmacy & Technologies
14
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
HIV
183
TB
169
COVID-19
139
Mental Health
107
Planetary Health
77
AMR
73
Global Health Education
71
Health Financing Toolbox
59
Disability
53
Caregiver
52
Conflict
48
Pharmacy
47
Rapid Response
45
NCDs
40
Ebola
37
NTDs
28
Refugee
23
Natural Hazards
22
Polio
8
Cholera
7
Social Ethics
4
Zika
3
Specific Hazards
2
Health Financing
2
Value in Health Regional Issues 4 C (2014) 37-40
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence of catastrophic health spending and impoverishing ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Following the 2014 Euromaidan Revolution, Ukraine embarked on a national reform program to reduce widespread corruption within government. In the health sector, the government introduced several complementary reforms that aimed to improve the health outcomes of Ukrainian citizens, but designed in su...
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
Fourth edition
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...
Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and
dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest
in their ND&IS and little is known about current financing alloca...
no cover page / publication year available
The process to develop this "National Traditional Medicine Policy" included a detailed situational analysis of traditional medicine in Liberia and a desk review of relevant documents and the regional policy framework on the alignment of WAHO countries ...
The process to develop this "National Traditional Medicine Policy" included a detailed situational analysis of traditional medicine in Liberia and a desk review of relevant documents and the regional policy framework on the alignment of WAHO countries ...
Promoting and protecting health is essential to human welfare and sustained economic and social development. This was recognized more than 30 years ago by the Alma-Ata Declaration signatories, who noted that Health for All would contribute
both to a better quality of life and also to global peace a...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides the most up-to-date estimates of development assistance for health, domestic spending on health, health spending on two key infectious diseases – malaria and HIV/AIDS – and fut...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
